A Phase 1-2 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients with Advanced Solid Tumors and Dose-Expansion in Patients with Non-Small Cell Lung Cancer Harboring c-MET Dysregulation
ABN-401
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 1-2 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients with Advanced Solid Tumors and Dose-Expansion in Patients with Non-Small Cell Lung Cancer Harboring c-MET Dysregulation ### Output: ABN-401